These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15257931)

  • 1. Gene expression profiles and risk stratification in childhood acute lymphoblastic leukemia.
    Teuffel O; Dettling M; Cario G; Stanulla M; Schrappe M; Bühlmann P; Niggli FK; Schäfer BW
    Haematologica; 2004 Jul; 89(7):801-8. PubMed ID: 15257931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.
    Yeoh EJ; Ross ME; Shurtleff SA; Williams WK; Patel D; Mahfouz R; Behm FG; Raimondi SC; Relling MV; Patel A; Cheng C; Campana D; Wilkins D; Zhou X; Li J; Liu H; Pui CH; Evans WE; Naeve C; Wong L; Downing JR
    Cancer Cell; 2002 Mar; 1(2):133-43. PubMed ID: 12086872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
    Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective Response Metric: a novel tool to predict relapse in childhood acute lymphoblastic leukaemia using time-series gene expression profiling.
    Yeoh AE; Li Z; Dong D; Lu Y; Jiang N; Trka J; Tan AM; Lin HP; Quah TC; Ariffin H; Wong L
    Br J Haematol; 2018 Jun; 181(5):653-663. PubMed ID: 29808917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].
    Bhojwani D; Kang H; Menezes RX; Yang W; Sather H; Moskowitz NP; Min DJ; Potter JW; Harvey R; Hunger SP; Seibel N; Raetz EA; Pieters R; Horstmann MA; Relling MV; den Boer ML; Willman CL; Carroll WL; ; ;
    J Clin Oncol; 2008 Sep; 26(27):4376-84. PubMed ID: 18802149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
    Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
    Avgeris M; Stamati L; Kontos CK; Piatopoulou D; Marmarinos A; Xagorari M; Baka M; Doganis D; Anastasiou T; Kosmidis H; Gourgiotis D; Scorilas A
    Clin Chem Lab Med; 2018 Nov; 56(12):2104-2118. PubMed ID: 30016275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of gene expression profiles that segregate patients with childhood leukemia.
    Moos PJ; Raetz EA; Carlson MA; Szabo A; Smith FE; Willman C; Wei Q; Hunger SP; Carroll WL
    Clin Cancer Res; 2002 Oct; 8(10):3118-30. PubMed ID: 12374679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia.
    Cario G; Stanulla M; Fine BM; Teuffel O; Neuhoff NV; Schrauder A; Flohr T; Schäfer BW; Bartram CR; Welte K; Schlegelberger B; Schrappe M
    Blood; 2005 Jan; 105(2):821-6. PubMed ID: 15388585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.
    Milani L; Lundmark A; Kiialainen A; Nordlund J; Flaegstad T; Forestier E; Heyman M; Jonmundsson G; Kanerva J; Schmiegelow K; Söderhäll S; Gustafsson MG; Lönnerholm G; Syvänen AC
    Blood; 2010 Feb; 115(6):1214-25. PubMed ID: 19965625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric acute lymphoblastic leukemia.
    Carroll WL; Bhojwani D; Min DJ; Raetz E; Relling M; Davies S; Downing JR; Willman CL; Reed JC
    Hematology Am Soc Hematol Educ Program; 2003; ():102-31. PubMed ID: 14633779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
    Downing JR
    Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients.
    Kohlmann A; Schoch C; Schnittger S; Dugas M; Hiddemann W; Kern W; Haferlach T
    Leukemia; 2004 Jan; 18(1):63-71. PubMed ID: 14603332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F3a gene expression has prognostic significance in childhood acute lymphoblastic leukemia.
    Wang KL; Mei YY; Cui L; Zhao XX; Li WJ; Gao C; Liu SG; Jiao Y; Liu FF; Wu MY; Ding W; Li ZG
    Eur J Haematol; 2014 Oct; 93(4):281-9. PubMed ID: 24758291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
    Cario G; Izraeli S; Teichert A; Rhein P; Skokowa J; Möricke A; Zimmermann M; Schrauder A; Karawajew L; Ludwig WD; Welte K; Schünemann HJ; Schlegelberger B; Schrappe M; Stanulla M
    J Clin Oncol; 2007 Oct; 25(30):4813-20. PubMed ID: 17947730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.
    Rzepiel A; Kutszegi N; Gézsi A; Sági JC; Egyed B; Péter G; Butz H; Nyírő G; Müller J; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
    J Transl Med; 2019 Nov; 17(1):372. PubMed ID: 31727091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.